Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Andy Pearce, Director of Discovery Partnerships with Academia at GSK joins the scheme as a Drug Discovery and Development Expert

The Business Development Team for the Medical Sciences Division has announced the appointment of a new  expert to its Industry Experts in Residence Scheme. Dr Andy Pearce, Director of Discovery Partnerships with Academia at GSK, joined the scheme in October. 

In his role Dr Pearce leads drug discovery projects from target validation through hit-finding and to the delivery of high quality clinical candidates, across broad disease areas, in collaboration with world-leading academic partners. He is a biochemist and cell biologist by training, and received his undergraduate degree and DPhil from the University of Oxford before undertaking postdoctoral studies at the University of Birmingham. Dr Pearce is a Fellow of the Royal Society of Biology, and he occasionally lectures at Oxford and Cambridge Universities and participates in career panels and workshops for scientists.

The Industry Experts in Residence programme is managed by the MSD Business Development Team and Oxford University Innovation. It aims to give Oxford's research community access to world-leading expertise and advice across multiple sectors. Researchers can arrange meetings with industry experts to discuss their ideas and projects, and attend seminars given by these experts on a wide range of topics.

Maxine Allen, Head of Business Development and Partnering for the Medical Sciences Division, commented: 'The Industry Experts in Residence scheme is a fantastic opportunity for our researchers to develop translational strategies for their projects, and an innovative way to foster interaction between industry and academia.'

The scheme currently hosts experts in product design in biomedical engineering, drug discovery, and digital health, and the appointment of Dr Pearce has made his expertise in Drug Discovery and Development available to researchers. Dr Pearce will sit in the Target Discovery Institute (TDI), Nuffield Department of Medicine, NDM Research Building on various dates during 2018/19. If you would like to arrange a meeting please contact charlotte.bell@medsci.ox.ac.uk

Find out more about the scheme and book an appointment with an expert 

Similar stories

New Transatlantic Partnership in Mental Health

Strategic Developments

The new partnership between Oxford Health NHS Foundation Trust, the University of Oxford, the University of Toronto, and the Centre for Addiction and Mental Health (CAMH) in Toronto, will enable the development of key structures to facilitate collaboration.

Oxford Awarded Major Funding to Probe Childhood Poverty and Social Inequalities

Strategic Developments

Ground-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.

David Paterson on the real value of research

Strategic Developments

Head of DPAG David Paterson joins Lord David Willets, Dame Ottoline Leyser and Priya Guha in discussing the future priorities for UK Research and Innovation (UKRI) - summaries are now published in The Foundation for Science and Technology Journal.

New WA Handley Chair of Psychiatry Appointed

Strategic Developments

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021.

Investigating New Treatment for Schizophrenia

Research Highlights Strategic Developments

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim has been announced to investigate a new drug target for the treatment of schizophrenia.

Retirement of Professor Peter Brown

Strategic Developments

This month sees the retirement of Professor Peter Brown as Director of the Medical Research Council Brain Network Dynamics Unit at the University of Oxford.